We are live on ! Find out more
JA

JLB & Associates Portfolio holdings

AUM $696M
1-Year Est. Return 17.86%
This Fund
S&P 500
This Quarter Est. Return
+5.86%
1 Year Est. Return
+17.86%
3 Year Est. Return
+57.72%
5 Year Est. Return
+93.63%
10 Year Est. Return
AUM
$409M
AUM Growth
+$15.5M
Cap. Flow
-$4.01M
Cap. Flow %
-0.98%
Top 10 Hldgs %
31.76%
Holding
74
New
1
Increased
26
Reduced
40
Closed
4

Top Buys

1
AON icon
Aon
AON
+$1.27M
2
HSIC icon
Henry Schein
HSIC
+$565K
3
LEA icon
Lear
LEA
+$560K
4
FDS icon
Factset
FDS
+$554K
5
DLX icon
Deluxe
DLX
+$515K

Sector Composition

1 Industrials 20.1%
2 Consumer Discretionary 19.61%
3 Technology 18%
4 Healthcare 12.14%
5 Consumer Staples 11.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VAR
26
DELISTED
Varian Medical Systems, Inc.
VAR
$8M 1.95%
79,969
+4,349
+6% +$446K
AME icon
27
Ametek
AME
$54.4B
$7.77M 1.9%
117,686
-3,399
-3% -$215K
CBRL icon
28
Cracker Barrel
CBRL
$1.14B
$7.46M 1.82%
49,225
+310
+0.6% +$47.4K
NKE icon
29
Nike
NKE
$66.1B
$7.15M 1.75%
137,949
+97
+0.1% +$5.45K
PII icon
30
Polaris
PII
$4.2B
$6.94M 1.7%
66,367
-1,563
-2% -$148K
CNI icon
31
Canadian National Railway
CNI
$77.8B
$6.4M 1.56%
77,208
+503
+0.7% +$40.8K
COL
32
DELISTED
Rockwell Collins
COL
$6.38M 1.56%
48,829
+2,043
+4% +$248K
DLTR icon
33
Dollar Tree
DLTR
$24.7B
$6.31M 1.54%
72,666
-665
-0.9% -$50.7K
ABBV icon
34
AbbVie
ABBV
$449B
$5.83M 1.42%
65,634
+5,285
+9% +$402K
SLGN icon
35
Silgan Holdings
SLGN
$5.01B
$5.81M 1.42%
197,342
-250
-0.1% -$7.6K
NVO
36
Novo Nordisk
NVO
$228B
$5.45M 1.33%
226,172
+1,890
+0.8% +$42.7K
SYK icon
37
Stryker
SYK
$127B
$5.11M 1.25%
35,990
-690
-2% -$98.9K
ORLY icon
38
O'Reilly Automotive
ORLY
$71.5B
$4.89M 1.19%
340,620
-7,110
-2% -$93.9K
HSIC icon
39
Henry Schein
HSIC
$10.1B
$4.27M 1.04%
66,359
+8,285
+14% +$565K
K
40
DELISTED
Kellanova
K
$3.5M 0.85%
59,722
-1,478
-2% -$93.3K
RTN
41
DELISTED
Raytheon Company
RTN
$3.43M 0.84%
18,375
+2,075
+13% +$366K
HBI
42
DELISTED
Hanesbrands
HBI
$2.81M 0.69%
114,187
-7,856
-6% -$188K
LEA icon
43
Lear
LEA
$7.2B
$2.65M 0.65%
15,317
+3,700
+32% +$560K
KMB icon
44
Kimberly-Clark
KMB
$36.2B
$2.63M 0.64%
22,392
-91
-0.4% -$11.1K
ALK icon
45
Alaska Air
ALK
$5.31B
$2.6M 0.64%
34,147
+3,710
+12% +$303K
EXPD icon
46
Expeditors International
EXPD
$23.8B
$2.5M 0.61%
41,711
-804
-2% -$46K
LH icon
47
Labcorp
LH
$23.1B
$2.49M 0.61%
19,232
-222
-1% -$29.6K
LLY icon
48
Eli Lilly
LLY
$1.04T
$2.39M 0.58%
27,961
-900
-3% -$73.8K
FDS icon
49
Factset
FDS
$9.33B
$2.12M 0.52%
11,753
+3,393
+41% +$554K
RHI icon
50
Robert Half
RHI
$4.23B
$2.03M 0.5%
40,321
+584
+1% +$27K

Similar funds

JLB & Associates's Q3 2017 Portfolio in Review

As of Q3 2017, JLB & Associates held 74 positions worth $409M, up 3.9% from $394M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

JLB & Associates's Q3 2017 filing shows 1 new, 26 increased, 40 reduced and 4 closed positions. Its largest new stake was Ubiquiti: 5,269 shares worth $295K. The largest sale was Medtronic, an estimated $1.54M.

By sector, the portfolio is most concentrated in Industrials at 20% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Technology.

  • JLB & Associates's largest Q3 2017 buy was Ubiquiti: 5,269 shares worth $295K.
  • JLB & Associates added most to Aon in Q3 2017, an estimated $1.27M increase.
  • JLB & Associates's biggest Q3 2017 reduction was Patterson Companies, Inc., cutting an estimated $1.52M.
  • JLB & Associates fully exited Medtronic in Q3 2017, selling an estimated $1.54M.
  • JLB & Associates's ten largest holdings make up 32% of its $409M portfolio in Q3 2017.
  • JLB & Associates opened 1 new position and closed 4 in Q3 2017.
  • JLB & Associates's portfolio value rose 3.9% quarter-over-quarter to $409M.

Based on JLB & Associates's 13F filing for Q3 2017, filed 12 Oct 2017.